Next Article in Journal
Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
Next Article in Special Issue
COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy
Previous Article in Journal
Dementia and COVID-19: A Case Report and Literature Review on Pain Management
Previous Article in Special Issue
Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(2), 200; https://doi.org/10.3390/ph15020200
Action Date Notes Link
article pdf uploaded. 5 February 2022 11:19 CET Version of Record https://www.mdpi.com/1424-8247/15/2/200/pdf-vor
article xml file uploaded 14 February 2022 08:34 CET Original file -
article xml uploaded. 14 February 2022 08:34 CET Update https://www.mdpi.com/1424-8247/15/2/200/xml
article pdf uploaded. 14 February 2022 08:34 CET Updated version of record https://www.mdpi.com/1424-8247/15/2/200/pdf
article html file updated 14 February 2022 08:36 CET Original file -
article html file updated 31 July 2022 10:56 CEST Update https://www.mdpi.com/1424-8247/15/2/200/html
Back to TopTop